OpenAI says it raised $40 billion funding, doubling its valuation to $300 billion
OpenAI has acquired $40 billion in new funding from SoftBank and other investors, valuing it at $300 billion. This funding ...
Daré Bioscience targets Q4 2025 for Sildenafil Cream launch via 503B compounding
Daré Bioscience's Q4 2024 earnings highlight a dual-path strategy for Sildenafil Cream, targeting 2025 revenue with 503B compounding while advancing ...